IL160030A0 - Treatment of muscular dystrophy with cord blood cells - Google Patents

Treatment of muscular dystrophy with cord blood cells

Info

Publication number
IL160030A0
IL160030A0 IL16003002A IL16003002A IL160030A0 IL 160030 A0 IL160030 A0 IL 160030A0 IL 16003002 A IL16003002 A IL 16003002A IL 16003002 A IL16003002 A IL 16003002A IL 160030 A0 IL160030 A0 IL 160030A0
Authority
IL
Israel
Prior art keywords
treatment
blood cells
cord blood
muscular dystrophy
dystrophy
Prior art date
Application number
IL16003002A
Other languages
English (en)
Original Assignee
Viacell Inc
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viacell Inc, Gen Hospital Corp filed Critical Viacell Inc
Publication of IL160030A0 publication Critical patent/IL160030A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16003002A 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells IL160030A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30722701P 2001-07-23 2001-07-23
PCT/US2002/023368 WO2003009857A1 (en) 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells

Publications (1)

Publication Number Publication Date
IL160030A0 true IL160030A0 (en) 2004-06-20

Family

ID=23188804

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16003002A IL160030A0 (en) 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells

Country Status (10)

Country Link
US (2) US7452529B2 (ja)
EP (1) EP1411957A1 (ja)
JP (1) JP2004536139A (ja)
CN (1) CN1638783A (ja)
BR (1) BR0211400A (ja)
CA (1) CA2455726A1 (ja)
HU (1) HUP0501108A3 (ja)
IL (1) IL160030A0 (ja)
PL (1) PL367979A1 (ja)
WO (1) WO2003009857A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
JP4902349B2 (ja) * 2004-06-11 2012-03-21 コンビ株式会社 筋ジストロフィー進行抑制組成物
US20100291042A1 (en) 2007-05-03 2010-11-18 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
EP2625263B1 (en) 2010-10-08 2020-03-11 Terumo BCT, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
CN104212760B (zh) 2013-05-29 2017-08-08 中国科学院上海生命科学研究院 肌肉干细胞体外培养方法及其应用
JP6401445B2 (ja) * 2013-10-10 2018-10-10 国立大学法人 東京大学 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法
JP6633522B2 (ja) 2013-11-16 2020-01-22 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
CA2988137C (en) 2015-06-11 2021-01-26 Maria Siemionow Muscular dystrophy chimeric cells and method for treating muscular dystrophies
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US5674750A (en) 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US20020051762A1 (en) 1998-01-23 2002-05-02 Shahin Rafii Purified populations of endothelial progenitor cells
EP1060242A4 (en) 1998-01-23 2003-09-17 Imclone Systems Inc PURIFIED POPULATIONS OF STEM CELLS

Also Published As

Publication number Publication date
WO2003009857A1 (en) 2003-02-06
US20030118565A1 (en) 2003-06-26
CA2455726A1 (en) 2003-02-06
BR0211400A (pt) 2004-11-09
CN1638783A (zh) 2005-07-13
JP2004536139A (ja) 2004-12-02
US7452529B2 (en) 2008-11-18
HUP0501108A2 (en) 2006-04-28
US20090068156A1 (en) 2009-03-12
HUP0501108A3 (en) 2006-11-28
PL367979A1 (en) 2005-03-21
EP1411957A1 (en) 2004-04-28
WO2003009857A8 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
HUP0501108A2 (en) Treatment of muscular dystrophy with cord blood cells
EP1412023A4 (en) METHOD AND DEVICE IN-VIVO FOR IMPROVING THE DIASTOLIC FUNCTION OF THE LEFT VENTRICLE
IL158618A0 (en) Biological pacemaker
IL166171A0 (en) Blood clot-targeted nanoparticles
IL218909A0 (en) Treatment of diabetes
GB2393202B (en) Methods of well treatment
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
GB0201674D0 (en) Medical treatment
CA97619S (en) Cardiac electrode
CA97620S (en) Medical electrode
GB0218879D0 (en) Medical treatment
AU2003219462A1 (en) Defibrillator/monitor with patient specific treatment algorithms
AU2003298664A1 (en) Treatment of cognitive dysfunctions'
LU91070B1 (en) Treatment and diagnosis of insulin resistant states
EP1435962A4 (en) TREATMENT OF DIABETES TYPE I
IL164951A0 (en) The treatment of pain with lfendropil
GB0300428D0 (en) Medical treatment
AU2003238227A1 (en) Treatment of blood with light
AU2002345895A1 (en) Medical oxygen concentrator
AU2002223718A1 (en) Analysis of longevity of patient treatment object
GB0127267D0 (en) Medical treatment
AU2003242826A1 (en) Blood treatment
GB0227865D0 (en) Medical Treatment
GB0220913D0 (en) Medical treatment